Journal of opioid management
-
Multicenter Study
12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.
To characterize the long-term safety and effectiveness of Hysingla™ ER, single-entity, once-daily, extended-release hydrocodone bitartrate tablets formulated with abuse-deterrent properties (HYD), offering a new treatment option for appropriate patients with chronic pain. ⋯ This long-term study demonstrated the safety and long-term maintenance of analgesic effect of HYD without continued need for dose increase.